Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (1-10 of 629) with videos related to

Pageof 63
Sort By:
Women'S Health (London, England)|July 6, 2010
Screening of women at high familial risk of breast cancerSteven A Narod
Breast (Edinburgh, Scotland)|November 10, 2017
Editorial: Approaches of the treatment of DCISSteven A Narod
Journal of the National Cancer Institute|April 15, 2015
Re: Survival outcomes after contralateral prophylactic mastectomy: a decision analysisSteven A Narod
Annals of Translational Medicine|May 14, 2023
Looking for <i>BRCA1</i> and <i>BRCA2</i> mutations in Asian women with breast cancerSteven A Narod
Nature Reviews. Cancer|March 15, 2003
Modifiers of risk of hereditary breast and ovarian cancerSteven A Narod
Breast Cancer Research and Treatment|March 16, 2018
Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?Steven A Narod
Breast Cancer Research and Treatment|September 1, 2017
Reply to KopansSteven A Narod
The New England Journal of Medicine|June 30, 2016
Weekly vs. Every-3-Week Paclitaxel for Ovarian CancerSteven A Narod
Nature Reviews. Clinical Oncology|July 20, 2021
Adjuvant olaparib - should all patients with breast cancer have genetic testing?Steven A Narod
Current Oncology (Toronto, Ont.)|January 20, 2021
Countercurrents: The Last TrialSteven A Narod
Pageof 63

Showing results (1-10 of 629) with videos related to

Sort By:
Pageof 63
Women'S Health (London, England)|July 6, 2010
Screening of women at high familial risk of breast cancerSteven A Narod
Breast (Edinburgh, Scotland)|November 10, 2017
Editorial: Approaches of the treatment of DCISSteven A Narod
Journal of the National Cancer Institute|April 15, 2015
Re: Survival outcomes after contralateral prophylactic mastectomy: a decision analysisSteven A Narod
Annals of Translational Medicine|May 14, 2023
Looking for <i>BRCA1</i> and <i>BRCA2</i> mutations in Asian women with breast cancerSteven A Narod
Nature Reviews. Cancer|March 15, 2003
Modifiers of risk of hereditary breast and ovarian cancerSteven A Narod
Breast Cancer Research and Treatment|March 16, 2018
Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?Steven A Narod
Breast Cancer Research and Treatment|September 1, 2017
Reply to KopansSteven A Narod
The New England Journal of Medicine|June 30, 2016
Weekly vs. Every-3-Week Paclitaxel for Ovarian CancerSteven A Narod
Nature Reviews. Clinical Oncology|July 20, 2021
Adjuvant olaparib - should all patients with breast cancer have genetic testing?Steven A Narod
Current Oncology (Toronto, Ont.)|January 20, 2021
Countercurrents: The Last TrialSteven A Narod
Pageof 63